Skip to content
777 Sourcing.

Capability

kinase-targeted drug discovery

Suppliers
1
States & provinces
1
Countries
1

1 kinase-targeted drug discovery supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

GEN1E LIFESCIENCES INC

PALO ALTO, CA

GEn1E Lifesciences is a clinical-stage, Phase 2 company accelerating first-in-class precision therapies for inflammatory and rare diseases. It discovered a new binding pocket and developed a unique, validated mechanism of action for Dual Signal Modulators targeting kinase dysregulation (p38, MK2, ERK). Its GRID AI platform supports its drug development. It received US FDA Orphan Drug and Rare Pediatric Disease designations for a dual signal modulator for Duchenne Muscular Dystrophy.

AI drug developmentclinical stage drug development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list kinase-targeted drug discovery.

Browse all capabilities